Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.37 |
| ▸ | EPAS1 | Q99814 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 2/20 | 0.33 |
| ▸ | FNTB | P49356 | 2/20 | 0.33 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4884623 | 0.79 | ALOX15 (0.52) | ALOX15HIF1AEPAS1TSHRFNTA | |
| SCHEMBL10919175 | 0.78 | MEN1 (0.32) | — | |
| SCHEMBL17058709 | 0.77 | ALOX15 (0.44) | ALOX15HIF1AEPAS1TSHRFNTA | |
| SCHEMBL11468233 | 0.77 | ALOX15 (0.42) | ALOX15HIF1AEPAS1TSHR | |
| SCHEMBL19074787 | 0.75 | MEN1 (0.30) | — | |
| SCHEMBL327189 | 0.73 | ALOX15 (0.59) | ALOX15HIF1AEPAS1TSHR | |
| SCHEMBL17580416 | 0.73 | MEN1 (0.43) | ALOX15 | |
| SCHEMBL3749023 | 0.73 | ALOX15 (0.45) | ALOX15HIF1AEPAS1TSHRFNTA | |
| SCHEMBL3755104 | 0.73 | ALOX15 (0.40) | ALOX15HIF1AEPAS1 | |
| SCHEMBL16482108 | 0.73 | ALOX15 (0.40) | ALOX15HIF1AEPAS1TSHRFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088725-B2 | Fragrance compositions and compounds | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2012-01-03 | — | — | US | disclosed |
| US-20100132249-A1 | Fragrance Compositions and Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2010-06-03 | — | — | US | disclosed |
| EP-2118249-A2 | FRAGRANCE COMPOSITIONS AND COMPOUNDS | Givaudan Nederland Services B.V. (NL) | 2009-11-18 | — | — | EP | disclosed |
| WO-2008092678-A2 | FRAGRANCE COMPOSITIONS AND COMPOUNDS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100132249-A1 | Fragrance Compositions and Compounds | H1-0, H1-10, H1-5 | ALOX15 355/4885HIF1A 931/4885EPAS1 1729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.